Tel Aviv University Launches Deep-Tech MBA for Scientists

Israel's newest companies aren't being built in coffee shops anymore. They're emerging from research labs, and the scientists behind them are learning an entirely new skillset to bring their discoveries to the world.

Tel Aviv University's Coller School of Management welcomed its first Deep-Tech Global MBA cohort in January 2026. The two-year program brings together engineers, scientists, and physicians from around the world who are working on breakthroughs that could take years to reach the market.

The timing reflects a major shift in Israel's famous startup ecosystem. For two decades, the country earned its "Startup Nation" reputation by launching companies designed to scale quickly. Now, more ventures are tackling complex scientific challenges in healthcare, energy, computing, agriculture, and manufacturing that require patient capital and specialized knowledge.

"Israel's success as the Startup Nation was built by people who saw the commercial potential in emerging technologies before the rest of the world did," says Yael Steinhart, Dean of the Coller School of Management. The new MBA aims to develop leaders who can anticipate where industries are headed and turn lab discoveries into global solutions.

The program addresses challenges unique to deep-tech founders. They must navigate intellectual property, technical validation, manufacturing, and commercialization long before their first product exists. Research and business development often happen simultaneously, blurring traditional lines between creating technology and building a company around it.

Students get hands-on exposure to Israel's deep-tech ecosystem through workshops, mentorship programs, and commercialization projects. Being at Tel Aviv University places them alongside professionals in engineering, computer science, and life sciences, making cross-disciplinary collaboration part of daily life.

The shift in education mirrors changes in how Israel funds early-stage companies. In June, the Israel Innovation Authority announced its Start-Up Fund, giving deep-tech ventures more resources to pursue ideas that cannot be built, tested, and launched overnight.

The Ripple Effect

The program's impact extends beyond individual companies. As more scientific breakthroughs emerge from Israeli labs, the country needs founders who can shepherd discoveries through the long journey from concept to commercial product. The scientists developing cancer treatments, clean energy solutions, and revolutionary computing systems need different skills than those building the next social app.

Training this new generation of founders could determine which scientific achievements stay confined to academic journals and which ones reshape industries and improve lives globally. Capital alone won't build successful deep-tech companies without leaders who understand both the science and the business.

Israel is betting that combining world-class research with entrepreneurs who know how to commercialize it will define the next chapter of innovation.